Severe acute respiratory syndrome-associated coronavirus IVDs

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Verfügbar ab:

Pale Blue Medical Trading Pty Ltd

Klasse:

Class 3

Hergestellt von:

Jiangsu Medomics Medical Technology Co Ltd F3 Building C No 3-1 Xinjinhu Road, Jiangbei new area, Nanjing Jiangsu, 210030 China

Therapiebereich:

CT772 - Severe acute respiratory syndrome-associated coronavirus IVDs

Anwendungsgebiete:

Intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19 from symptomatic individuals at the point of care by trained health professionals (anterior nasal, nasopharyngeal and throat samples) and for self-testing by lay persons (nasal swab).

Berechtigungsstatus:

A

Berechtigungsdatum:

2021-12-13